Borwin Bandelow

Summary

Country: Germany

Publications

  1. ncbi request reprint Treatment-resistant panic disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    CNS Spectr 9:725-39. 2004
  2. ncbi request reprint Salivary cortisol in panic attacks
    B Bandelow
    Department of Psychiatry, The University of Göttingen, Germany
    Am J Psychiatry 157:454-6. 2000
  3. ncbi request reprint [Behavior therapy and antidepressive drugs. What helps with anxiety?]
    B Bandelow
    Klinik für Psychiatrie und Psychotherapie der Universität Göttingen
    MMW Fortschr Med . 2002
  4. ncbi request reprint World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    World J Biol Psychiatry 3:171-99. 2002
  5. ncbi request reprint Separation anxiety and actual separation experiences during childhood in patients with panic disorder
    B Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    Can J Psychiatry 46:948-52. 2001
  6. ncbi request reprint The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
    B Bandelow
    Department of Psychiatry, University of Gottingen, Germany
    Pharmacopsychiatry 33:174-81. 2000
  7. ncbi request reprint Diurnal variation of cortisol in panic disorder
    B Bandelow
    Department of Psychiatry, University of Gottingen, Von Siebold Strasse 5, D 37075, Gottingen, Germany
    Psychiatry Res 95:245-50. 2000
  8. ncbi request reprint The use of the Panic and Agoraphobia Scale in a clinical trial
    B Bandelow
    Department of Psychiatry, The University of Göttingen, Germany
    Psychiatry Res 77:43-9. 1998
  9. ncbi request reprint Application of a new statistical approach to evaluate a clinical trial with panic disorder patients
    B Bandelow
    Department of Psychiatry, University of Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 249:21-7. 1999
  10. ncbi request reprint Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, D 37505 Göttingen, Germany
    J Clin Psychiatry 65:405-13. 2004

Collaborators

Detail Information

Publications68

  1. ncbi request reprint Treatment-resistant panic disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    CNS Spectr 9:725-39. 2004
    ..According to existing studies, a combination of pharmacologic treatment with cognitive-behavioral therapy can be recommended...
  2. ncbi request reprint Salivary cortisol in panic attacks
    B Bandelow
    Department of Psychiatry, The University of Göttingen, Germany
    Am J Psychiatry 157:454-6. 2000
    ..Increased cortisol levels have been associated with altered HPA function due to stress. The authors examined salivary cortisol levels in spontaneously occurring, unprovoked panic attacks...
  3. ncbi request reprint [Behavior therapy and antidepressive drugs. What helps with anxiety?]
    B Bandelow
    Klinik für Psychiatrie und Psychotherapie der Universität Göttingen
    MMW Fortschr Med . 2002
    ..Selective serotonin reuptake inhibitors are the medication of first choice in anxiety disorders and comorbid depression...
  4. ncbi request reprint World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    World J Biol Psychiatry 3:171-99. 2002
    ..For social phobia, SSRIs are recommended for the first line, and MAOIs, moclobemide and benzodiazepines as second line. Obsessive-compulsive disorder is best treated with SSRIs or clomipramine...
  5. ncbi request reprint Separation anxiety and actual separation experiences during childhood in patients with panic disorder
    B Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    Can J Psychiatry 46:948-52. 2001
    ..The association between separation anxiety in childhood and actual separation experiences during childhood has not yet been investigated in patients with panic disorder...
  6. ncbi request reprint The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
    B Bandelow
    Department of Psychiatry, University of Gottingen, Germany
    Pharmacopsychiatry 33:174-81. 2000
    ..At the same time, the aim of the study was to compare the therapeutic effects of aerobic exercise with a treatment of well-documented efficacy...
  7. ncbi request reprint Diurnal variation of cortisol in panic disorder
    B Bandelow
    Department of Psychiatry, University of Gottingen, Von Siebold Strasse 5, D 37075, Gottingen, Germany
    Psychiatry Res 95:245-50. 2000
    ..Cortisol elevations seem to be more pronounced during the night and occurred mainly in more severely ill panic patients...
  8. ncbi request reprint The use of the Panic and Agoraphobia Scale in a clinical trial
    B Bandelow
    Department of Psychiatry, The University of Göttingen, Germany
    Psychiatry Res 77:43-9. 1998
    ..The new Panic and Agoraphobia Scale (P & A) is a useful tool for measuring treatment efficacy in panic disorder trials...
  9. ncbi request reprint Application of a new statistical approach to evaluate a clinical trial with panic disorder patients
    B Bandelow
    Department of Psychiatry, University of Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 249:21-7. 1999
    ....
  10. ncbi request reprint Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, D 37505 Göttingen, Germany
    J Clin Psychiatry 65:405-13. 2004
    ..The purpose of this study was to compare sertraline and paroxetine in the acute treatment of panic disorder...
  11. ncbi request reprint What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    J Clin Psychiatry 67:1428-34. 2006
    ..We also sought to compare the standardized effect sizes of escitalopram for these 4 psychiatric disorders...
  12. doi request reprint Association analysis of Rgs7 variants with panic disorder
    Christa Hohoff
    Department of Psychiatry, University of Muenster, Muenster, Germany
    J Neural Transm 116:1523-8. 2009
    ..Our results argue against a major role of Rgs7 gene variants in the pathogenesis of PD, but are consistent with a minor gender-specific effect on PD, particularly PDAgP...
  13. doi request reprint Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality
    Christa Hohoff
    Department of Psychiatry, University of Muenster, Albert Schweitzer Strasse 11, 48149 Muenster, Germany
    J Psychiatr Res 44:930-7. 2010
    ..Our data provide further support for an important role of ADORA2A variants in the pathogenesis of anxiety disorders and anxious personality reflecting their potential as basic susceptibility factors...
  14. ncbi request reprint Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
    Borwin Bandelow
    Dept of Psychiatry and Psychotherapy, The University of Göttingen, Von Siebold Str 5, 37075 Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 254:397-405. 2004
    ..Childhood traumatic experiences, rearing styles, familial mental disorders and birth risk factors have been associated with the development of social anxiety disorder...
  15. doi request reprint A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder
    Dirk Wedekind
    Department of Psychiatry and Psychotherapy, University of Goettingen, Goettingen, Germany
    World J Biol Psychiatry 11:904-13. 2010
    ..Regular aerobic exercise (running) has been shown to be superior to a pill placebo in the treatment of panic disorder. Combined drug and exercise treatment has not been investigated in randomized controlled studies to date...
  16. ncbi request reprint 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo
    Andreas Broocks
    Department of Psychiatry and Psychotherapy, University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur Neuropsychopharmacol 13:153-64. 2003
    ..In conclusion, our results demonstrate that effective treatment of panic disorder has divergent effects on the psychological, neuroendocrine and temperature responses to ipsapirone...
  17. doi request reprint Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Int J Psychiatry Clin Pract 16:77-84. 2012
    ..Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners...
  18. ncbi request reprint Panic disorder during pregnancy and postpartum period
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    Eur Psychiatry 21:495-500. 2006
    ..Earlier studies on the influence of pregnancy and postpartum period on the course of panic disorder have been inconsistent. The present study aims to quantify panic manifestations in these periods in large sample of women...
  19. ncbi request reprint The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity
    Dirk Wedekind
    Department of Psychiatry, University of Gottingen, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 257:153-63. 2007
    ..Characteristic cognitive and behavioural domains, representing severity are not incorporated in the existing scales. Results with the novel quantification inventory for somatoform syndromes (QUISS) are presented in this paper...
  20. ncbi request reprint Disorder-specific emotional imagery for differential and quantitative assessment of agoraphobia
    Kirsten Rita Engel
    Dept of Psychiatry and Psychotherapy, University of Goettingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
    Curr Pharm Des 18:5638-44. 2012
    ..It could be used for the differential assessment of PDA and associated neurobiological and psychological phenomena and in neuroimaging paradigms...
  21. pmc Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder
    Heike Weber
    Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wurzburg, Wurzburg, Germany
    PLoS ONE 7:e37651. 2012
    ..In a recent association study in depression, which is highly comorbid with panic disorder, GAD1 risk allele associations were restricted to females...
  22. ncbi request reprint Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, D 37075, Gottingen, Germany
    Psychiatry Res 134:169-79. 2005
    ..The present data support the hypothesis that the etiology of BPD is multifactorial and that familial psychiatric disorders and sexual abuse are contributing factors...
  23. doi request reprint World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    World J Biol Psychiatry 9:248-312. 2008
    ....
  24. ncbi request reprint Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
    Compr Psychiatry 43:269-78. 2002
    ..Owing to the retrospective nature of the data, the results have to be interpreted with caution...
  25. doi request reprint Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion
    Dirk Wedekind
    Dept of Psychiatry and Psychotherapy, University of Goettingen, Von Siebold Strasse 5, D 37075 Gottingen, Germany
    J Psychiatr Res 44:1163-9. 2010
    ..Patients with the ll genotype of the serotonin transporter gene displayed lower baseline tryptophan levels compared to patients with the heterozygous genotype. Results suggest an impaired serotonergic function in alcohol-addicted males...
  26. ncbi request reprint What treatments do patients with panic disorder and agoraphobia get?
    B Bandelow
    Department of Psychiatry, University of Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 245:165-71. 1995
    ..9) were not rated highly effective by the patients. Among psychological treatments, patients were more satisfied with behavioural/cognitive therapy (2.6) than with psychodynamic therapies (1.5).(ABSTRACT TRUNCATED AT 250 WORDS)..
  27. doi request reprint Borderline personality disorder: a dysregulation of the endogenous opioid system?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Psychol Rev 117:623-36. 2010
    ..An understanding of the neurobiology of BPD may help in developing new treatments for patients with this severe disorder...
  28. ncbi request reprint Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
    World J Biol Psychiatry 8:175-87. 2007
    ..We performed a meta-analysis, which only included studies using a direct comparison of pharmacological, psychological, or combined treatments...
  29. ncbi request reprint Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
    D Naber
    Department of Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Germany
    Acta Psychiatr Scand 111:106-15. 2005
    ..This randomized double-blind multicenter trial evaluated the effects of olanzapine vs. clozapine on subjective well-being, quality of life (QOL) and clinical outcome...
  30. doi request reprint Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with depressive disorder and healthy controls
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Int J Psychiatry Clin Pract 17:56-63. 2013
    ..Only few studies have compared the frequency of traumatic life events during childhood in inpatients with depression with a healthy control group...
  31. doi request reprint Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    World J Biol Psychiatry 11:66-70. 2010
    ..0195), respectively, was observed. The present results provide further support for a potentially male-specific role of the less active ACE I allele in the pathogenesis of panic disorder, possibly by altering substance P levels...
  32. ncbi request reprint Escitalopram in the treatment of anxiety symptoms associated with depression
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Depress Anxiety 24:53-61. 2007
    ..Escitalopram was significantly more effective compared to placebo in treating both anxiety symptoms and the entire depression in the total depressive population, as well as in depressive patients with a high degree of anxiety...
  33. doi request reprint Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Goettingen, Germany
    Int J Neuropsychopharmacol 13:305-20. 2010
    ..8%, 150 mg, 5.0%; placebo, 1.8%; and paroxetine, 8.4%. Once-daily quetiapine XR is an effective and generally well-tolerated treatment for patients with GAD, with symptom improvement seen as early as day 4...
  34. ncbi request reprint Defining response and remission in anxiety disorders: toward an integrated approach
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    CNS Spectr 11:21-8. 2006
    ....
  35. ncbi request reprint [Early detection of anxiety disorders]
    D Wedekind
    Klinik fur Psychiatrie und Psychotherapie, Georg August Universitat Gottingen
    MMW Fortschr Med 149:32-5. 2007
    ..Previously existing symptoms almost always include depressive moods or avoidance behavior. Stressful life events and other psychosocial stressful factors may also point the way to the early diagnosis of an anxiety disorder...
  36. ncbi request reprint Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder
    D Wedekind
    Department of Psychiatry and Psychotherapy, University of Goettingen, Von Siebold Strasse 5, D 37075 Goettingen, Germany
    Curr Pharm Des 14:3518-24. 2008
    ..Data on basal hypothalamo-pituitary-adrenomedullary (HPA) function over controlled treatment trials with serotonergic drugs in anxiety disorders are still rare...
  37. ncbi request reprint [Pharmacotherapy in personality disorders]
    D Wedekind
    Klinik für Psychiatrie und Psychotherapie der Georg August Universität Göttingen
    Fortschr Neurol Psychiatr 73:259-67. 2005
    ..Response rates vary among the trials and appear to be lower than in non-comorbid axis-I disorders. A treatment algorithm is presented...
  38. ncbi request reprint [Anxiety-ridden patients in the doctor's office]
    D Wedekind
    Klinik für Psychiatrie und Psychotherapie der Georg August Universität Göttingen
    MMW Fortschr Med 146:24-6. 2004
    ..Early detection and treatment of an anxiety disorder can prevent the condition from becoming chronic and may also obviate the need for unnecessary repeated diagnostic measures and treatments...
  39. ncbi request reprint Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment
    B A Haug
    Department of Neurology and Clinical Neurophysiology, Georg August University, Gottingen, Germany
    Vision Res 37:3535-47. 1997
    ..01), with little change in the extent of transient tritanopia. The same tendency at a lower significance level was found in 15 psychiatric patients under chronic treatment with depot neuroleptics...
  40. ncbi request reprint Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases
    G Hajak
    Department of Psychiatry, Georg August University of Gottingen, Germany
    Int Clin Psychopharmacol 13:157-67. 1998
    ..No life-threatening adverse event occurred. The adverse event profile reflected the pharmacological properties of zolpidem and underlined the cumulative good experience with the drug internationally...
  41. ncbi request reprint Rebound insomnia after hypnotic withdrawal in insomniac outpatients
    G Hajak
    Department of Psychiatry, , Germany
    Eur Arch Psychiatry Clin Neurosci 248:148-56. 1998
    ..This result indicates that a deterioration of sleep after drug withdrawal is not apparent during a few days but may last for longer periods in some patients and is modified by marked night-to-night variations...
  42. ncbi request reprint Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder
    J Pauls
    Department of Psychiatry, University of Gottingen, Federal Republic of Germany
    J Neural Transm 107:1361-6. 2000
    ..A previously reported genetic association (Arinami et al., 1996) was not confirmed by the present study...
  43. ncbi request reprint Clozapine-associated elevation of plasma cholinesterase
    J Wiltfang
    Department of Psychiatry and Psychotherapy, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 251:269-71. 2001
    ..The goal of this study was to identify adverse effects of the atypical neuroleptic clozapine on liver function and lipid metabolism...
  44. ncbi request reprint Endurance training in panic patients: spiroergometric and clinical effects
    T Meyer
    Department of Psychiatry, The University of Göttingen, Germany
    Int J Sports Med 19:496-502. 1998
    ..Panic patients were shown to have a decreased endurance capacity which can be raised by training. Endurance training based on spiroergometric results gives rise to clinical improvement...
  45. pmc Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, 37075, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 262:459-67. 2012
    ..8% vs. 5.17%). A careful psychiatric screening before recruitment might help to identify persons at risk of PTSD...
  46. ncbi request reprint Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention
    Borwin Bandelow
    University of Gottingen, Department of Psychiatry and Psychotherapy, Von Siebold Str 5, D 37075 Gottingen, Germany
    Expert Rev Neurother 7:769-81. 2007
    ..Clinicians may consider the use of pregabalin in lieu of benzodiazepines as an alternative therapy for their patients with GAD...
  47. ncbi request reprint Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants
    Katharina Domschke
    Department of Psychiatry, University of Muenster, Muenster, Germany
    Am J Med Genet B Neuropsychiatr Genet 147:510-6. 2008
    ..However, in order to allow for conclusive evaluation of the present finding and to exclude a false positive result, further studies in larger, independent, preferably family based samples are warranted...
  48. ncbi request reprint Rgs 2 gene polymorphisms as modulators of anxiety in humans?
    A Leygraf
    Laboratory of Molecular Psychiatry, Department of Psychiatry, University of Munster, Munster, Germany
    J Neural Transm 113:1921-5. 2006
    ..01 and 0.03). This points towards a functional polymorphism at the 3' end of the gene. Our results support the hypothesis that variations of the Rgs2 gene play a role also for the development of anxiety in humans...
  49. ncbi request reprint Blood dyscrasias induced by psychotropic drugs
    S Stubner
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S70-8. 2004
    ..01 %). Although the methodological accuracy of these findings has to be critically discussed these data could be of considerable clinical relevance and should be helpful in making clinical treatment decisions...
  50. ncbi request reprint Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich
    B Bandelow
    Department of Psychiatry, , Federal Republic of Germany
    Eur Arch Psychiatry Clin Neurosci 240:113-20. 1990
    ..These results are interpreted on the basis of hypotheses about depressive syndromes in schizophrenia...
  51. pmc The diagnosis and treatment of generalized anxiety disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University Medical Center Gottingen, Germany
    Dtsch Arztebl Int 110:300-9; quiz 310. 2013
    ..Generalized anxiety disorder (GAD) is a common and serious disease with a lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care...
  52. pmc Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatients
    Dirk Wedekind
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
    Subst Abuse Treat Prev Policy 8:1. 2013
    ....
  53. pmc Neuroimaging in anxiety disorders
    Kirsten Engel
    Department of Psychiatry and Psychotherapy, Anxiety Research Unit, University of Goettingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
    J Neural Transm 116:703-16. 2009
    ..An overview of neuroimaging investigations in anxiety disorders is given after a brief summary of results from healthy volunteers. Concluding implications for future research are made by the authors...
  54. ncbi request reprint Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects
    A Broocks
    Department of Psychiatry and Psychotherapy, University of Lubeck, Germany
    Psychopharmacology (Berl) 155:234-41. 2001
    ..Several clinical studies suggest antidepressive and anxiolytic effects of regular aerobic exercise...
  55. ncbi request reprint Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
    A Broocks
    Department of Psychiatry and Psychotherapy, University of Lubeck, 23538 Lubeck, Germany
    Neuropsychopharmacology 27:270-8. 2002
    ..The prevention of smoking during challenge sessions might not be the ideal approach in heavy smokers, since sudden abstinence from smoking is likely to affect neurobiological and possibly psychological responses to ipsapirone...
  56. ncbi request reprint Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany
    B Bandelow
    Department of Psychiatry, , Federal Republic of Germany
    Eur Arch Psychiatry Clin Neurosci 241:291-5. 1992
    ..No differences were found between patients treated with low versus high potency neuroleptics and between oral versus depot neuroleptics. However, depression correlated with extrapyramidal symptoms...
  57. ncbi request reprint Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo
    B Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Pharmacopsychiatry 40:152-6. 2007
    ..It has been argued that measurement of outcome in panic disorder should not be limited to monitoring the number of panic attacks, but should include all domains that affect patient quality of life...
  58. ncbi request reprint "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting
    Goran Hajak
    Department of Psychiatry and Psychotherapy, University of Regensburg, Germany
    Ann Clin Psychiatry 14:1-7. 2002
    ..Further research is warranted on the contributions of both treatment components to effectiveness and on the efficacy and safety issues of long-term use...
  59. ncbi request reprint Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism
    S Bleich
    Department of Psychiatry and Psychotherapy, Friedrich Alexander University of Erlangen Nuremberg, Schwabachanlage 6 10, D 91054 Erlangen, Germany
    Neurosci Lett 335:179-82. 2003
    ..001, multiple regression analysis). Raised plasma levels of homocysteine are associated with hippocampal (brain) atrophy in alcoholism...
  60. ncbi request reprint WCA Recommendations for the long-term treatment of posttraumatic stress disorder
    Dan J Stein
    Medical Research Council Research Unit on Anxiety Disorder, University of Stellenbosch, Cape Town, Tygerberg, South Africa
    CNS Spectr 8:31-9. 2003
    ..Only SSRIs have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12-24 months...
  61. ncbi request reprint WCA recommendations for the long-term treatment of generalized anxiety disorder
    Christer Allgulander
    Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
    CNS Spectr 8:53-61. 2003
    ..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
  62. ncbi request reprint WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults
    John H Greist
    Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
    CNS Spectr 8:7-16. 2003
    ..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered...
  63. ncbi request reprint Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
    David S Baldwin
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK
    J Psychopharmacol 19:567-96. 2005
    ..The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments...
  64. ncbi request reprint WCA recommendations for the long-term treatment of panic disorder
    Mark H Pollack
    Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
    CNS Spectr 8:17-30. 2003
    ..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
  65. ncbi request reprint WCA recommendations for the long-term treatment of social phobia
    Michael Van Ameringen
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    CNS Spectr 8:40-52. 2003
    ..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
  66. ncbi request reprint Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
    Dan J Stein
    Department of Psychiatry, University of Cape Town, South Africa
    J Clin Psychiatry 67:1741-6. 2006
    ....
  67. ncbi request reprint Assessing the severity of panic disorder and agoraphobia: validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A)
    Umit Tural
    School of Medicine, Dokuz Eylul University, Izmir, Turkey
    J Anxiety Disord 16:331-40. 2002
    ..88 and .86, respectively. The Turkish version of the P&A has yielded good psychometric properties and was found to be a reliable instrument for assessing severity in panic disorder...
  68. doi request reprint Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder
    Martin E Keck
    Max Planck Institute of Psychiatry, Munich, Germany
    Am J Med Genet B Neuropsychiatr Genet 147:1196-204. 2008
    ..These data suggest that polymorphisms in the AVPR1B and the CRHR1 genes alter the susceptibility to panic disorder...